<!-- Generated by pkgdown: do not edit by hand -->
<!DOCTYPE html>
<html lang="en">
  <head>
  <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1.0">

<title>Assign ESMO 2020 — assign_esmo2020 • EndoTools</title>


<!-- jquery -->
<script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/3.4.1/jquery.min.js" integrity="sha256-CSXorXvZcTkaix6Yvo6HppcZGetbYMGWSFlBw8HfCJo=" crossorigin="anonymous"></script>
<!-- Bootstrap -->
<link href="https://cdnjs.cloudflare.com/ajax/libs/bootswatch/3.4.0/cerulean/bootstrap.min.css" rel="stylesheet" crossorigin="anonymous" />


<script src="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/3.4.1/js/bootstrap.min.js" integrity="sha256-nuL8/2cJ5NDSSwnKD8VqreErSWHtnEP9E7AySL+1ev4=" crossorigin="anonymous"></script>

<!-- bootstrap-toc -->
<link rel="stylesheet" href="../bootstrap-toc.css">
<script src="../bootstrap-toc.js"></script>

<!-- Font Awesome icons -->
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/all.min.css" integrity="sha256-mmgLkCYLUQbXn0B1SRqzHar6dCnv9oZFPEC1g1cwlkk=" crossorigin="anonymous" />
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/v4-shims.min.css" integrity="sha256-wZjR52fzng1pJHwx4aV2AO3yyTOXrcDW7jBpJtTwVxw=" crossorigin="anonymous" />

<!-- clipboard.js -->
<script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script>

<!-- headroom.js -->
<script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/headroom.min.js" integrity="sha256-AsUX4SJE1+yuDu5+mAVzJbuYNPHj/WroHuZ8Ir/CkE0=" crossorigin="anonymous"></script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/jQuery.headroom.min.js" integrity="sha256-ZX/yNShbjqsohH1k95liqY9Gd8uOiE1S4vZc+9KQ1K4=" crossorigin="anonymous"></script>

<!-- pkgdown -->
<link href="../pkgdown.css" rel="stylesheet">
<script src="../pkgdown.js"></script>




<meta property="og:title" content="Assign ESMO 2020 — assign_esmo2020" />
<meta property="og:description" content="Assign ESMO 2020 based on stage, grade, histological subtype group,
myometrial invasion, and LVSI. Molecular classification and residual disease
can be used if available." />




<!-- mathjax -->
<script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js" integrity="sha256-nvJJv9wWKEm88qvoQl9ekL2J+k/RWIsaSScxxlsrv8k=" crossorigin="anonymous"></script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/config/TeX-AMS-MML_HTMLorMML.js" integrity="sha256-84DKXVJXs0/F8OTMzX4UR909+jtl4G7SPypPavF+GfA=" crossorigin="anonymous"></script>

<!--[if lt IE 9]>
<script src="https://oss.maxcdn.com/html5shiv/3.7.3/html5shiv.min.js"></script>
<script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
<![endif]-->



  </head>

  <body data-spy="scroll" data-target="#toc">
    <div class="container template-reference-topic">
      <header>
      <div class="navbar navbar-default navbar-fixed-top" role="navigation">
  <div class="container">
    <div class="navbar-header">
      <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#navbar" aria-expanded="false">
        <span class="sr-only">Toggle navigation</span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <span class="navbar-brand">
        <a class="navbar-link" href="../index.html">EndoTools</a>
        <span class="version label label-default" data-toggle="tooltip" data-placement="bottom" title="Released version">0.3.3</span>
      </span>
    </div>

    <div id="navbar" class="navbar-collapse collapse">
      <ul class="nav navbar-nav">
        <li>
  <a href="../index.html">
    <span class="fas fa-home fa-lg"></span>
     
  </a>
</li>
<li>
  <a href="../reference/index.html">Reference</a>
</li>
<li>
  <a href="../news/index.html">Changelog</a>
</li>
      </ul>
      <ul class="nav navbar-nav navbar-right">
        <li>
  <a href="https://github.com/TalhoukLab/EndoTools">
    <span class="fa fa-github"></span>
     
  </a>
</li>
      </ul>
      
    </div><!--/.nav-collapse -->
  </div><!--/.container -->
</div><!--/.navbar -->

      

      </header>

<div class="row">
  <div class="col-md-9 contents">
    <div class="page-header">
    <h1>Assign ESMO 2020</h1>
    
    <div class="hidden name"><code>assign_esmo2020.Rd</code></div>
    </div>

    <div class="ref-description">
    <p>Assign ESMO 2020 based on stage, grade, histological subtype group,
myometrial invasion, and LVSI. Molecular classification and residual disease
can be used if available.</p>
    </div>

    <pre class="usage"><span class='fu'>assign_esmo2020</span><span class='op'>(</span>
  <span class='va'>stage_full</span>,
  <span class='va'>grade</span>,
  <span class='va'>hist_gr</span>,
  <span class='va'>myo</span>,
  <span class='va'>lvi</span>,
  eclass <span class='op'>=</span> <span class='cn'>NULL</span>,
  residual <span class='op'>=</span> <span class='cn'>NULL</span>
<span class='op'>)</span></pre>

    <h2 class="hasAnchor" id="arguments"><a class="anchor" href="#arguments"></a>Arguments</h2>
    <table class="ref-arguments">
    <colgroup><col class="name" /><col class="desc" /></colgroup>
    <tr>
      <th>stage_full</th>
      <td><p>FIGO stage: I, II, III, IV with substages</p></td>
    </tr>
    <tr>
      <th>grade</th>
      <td><p>tumour grade: 1, 2, 3</p></td>
    </tr>
    <tr>
      <th>hist_gr</th>
      <td><p>histological subtype group: endometrioid or non-endometrioid</p></td>
    </tr>
    <tr>
      <th>myo</th>
      <td><p>myometrial invasion: none, 1-50%, &gt;50%</p></td>
    </tr>
    <tr>
      <th>lvi</th>
      <td><p>lymphovascular space invasion: negative, positive, focal, extensive</p></td>
    </tr>
    <tr>
      <th>eclass</th>
      <td><p>molecular classification: "MMRd", "POLEmut", "p53abn", or
"NSMP/p53wt"</p></td>
    </tr>
    <tr>
      <th>residual</th>
      <td><p>residual disease: "&lt;1cm", "&gt;=1cm", "microscopic", or "no
residual". Use if available. Microscopic residual is regarded as no
residual disease.</p></td>
    </tr>
    </table>

    <h2 class="hasAnchor" id="value"><a class="anchor" href="#value"></a>Value</h2>

    <p>ESMO 2020 assigned into "low", "intermediate", "high-intermediate",
"high", "advanced", or "metastatic". Unassignable cases are <code>NA</code>.</p>
    <h2 class="hasAnchor" id="details"><a class="anchor" href="#details"></a>Details</h2>

    <p>ESMO 2020 is assigned using stage, grade, histological subtype group,
myometrial invasion, and LVSI into low, intermediate, high-intermediate,
high, advanced, and metastatic risk based on the following criteria with and
without molecular classification/residual disease:</p>
<p><strong>With molecular classification</strong></p><ul>
<li><p>low:</p><ul>
<li><p>stage I-II, POLEmut, (no residual disease if known)</p><ul>
<li><p>missing residual disease is regarded as no residual disease</p></li>
</ul></li>
<li><p>stage IA, grade 1/2, endometrioid, LVSI negative or focal, MMRd/NSMP</p></li>
</ul></li>
<li><p>intermediate:</p><ul>
<li><p>stage IB, grade 1/2, endometrioid, LVSI negative or focal, MMRd/NSMP</p></li>
<li><p>stage IA, grade 3, endometrioid, LVSI negative or focal, MMRd/NSMP</p></li>
<li><p>stage IA, no myometrial invasion, p53abn</p></li>
</ul></li>
<li><p>high-intermediate:</p><ul>
<li><p>stage IA/IB, endometrioid, LVSI positive or extensive, MMRd/NSMP</p></li>
<li><p>stage IB, grade 3, endometrioid, MMRd/NSMP</p></li>
<li><p>stage II/IIA, endometrioid, MMRd/NSMP</p></li>
</ul></li>
<li><p>high:</p><ul>
<li><p>stage III-IVA, endometrioid, MMRd/NSMP, (no residual disease if known)</p></li>
<li><p>stage I-IVA, &gt;0% myometrial invasion, p53abn, (no residual disease if known)</p><ul>
<li><p>for stage I-II, missing residual disease is regarded as no residual disease</p></li>
</ul></li>
<li><p>stage IA, non-endometrioid or mixed subtype, &gt;0% myometrial invasion, MMRd/NSMP, (no residual disease if known)</p><ul>
<li><p>missing residual disease is regarded as no residual disease</p></li>
</ul></li>
<li><p>stage IB-IVA, non-endometrioid or mixed subtype, MMRd/NSMP, (no residual disease if known)</p><ul>
<li><p>for stage IB-II, missing residual disease is regarded as no residual disease</p></li>
</ul></li>
</ul></li>
<li><p>advanced:</p><ul>
<li><p>stage III-IVA, any molecular type, (with residual disease if known)</p></li>
</ul></li>
<li><p>metastatic:</p><ul>
<li><p>stage IVB, any molecular type</p></li>
</ul></li>
</ul>

<p><strong>Without molecular classification</strong></p><ul>
<li><p>low:</p><ul>
<li><p>stage IA, grade 1/2, endometrioid, LVSI negative or focal</p></li>
</ul></li>
<li><p>intermediate:</p><ul>
<li><p>stage IB, grade 1/2, endometrioid, LVSI negative or focal</p></li>
<li><p>stage IA, grade 3, endometrioid, LVSI negative or focal</p></li>
<li><p>stage IA, no myometrial invasion</p></li>
</ul></li>
<li><p>high-intermediate:</p><ul>
<li><p>stage IA/IB, endometrioid, LVSI positive or extensive</p></li>
<li><p>stage IB, grade 3, endometrioid</p></li>
<li><p>stage II/IIA, endometrioid</p></li>
</ul></li>
<li><p>high:</p><ul>
<li><p>stage III-IVA, endometrioid, (no residual disease if known)</p></li>
<li><p>stage IA, non-endometrioid or mixed subtype, &gt;0% myometrial invasion, (no residual disease if known)</p><ul>
<li><p>missing residual disease is regarded as no residual disease</p></li>
</ul></li>
<li><p>stage IB-IVA, non-endometrioid or mixed subtype, (no residual disease if known)</p><ul>
<li><p>for stage IB-II, missing residual disease is regarded as no residual disease</p></li>
</ul></li>
</ul></li>
<li><p>advanced:</p><ul>
<li><p>stage III-IVA, (with residual disease if known)</p></li>
</ul></li>
<li><p>metastatic:</p><ul>
<li><p>stage IVB</p></li>
</ul></li>
</ul>

    <h2 class="hasAnchor" id="note"><a class="anchor" href="#note"></a>Note</h2>

    <p>Assignment starts from the low group first.</p>
    <h2 class="hasAnchor" id="references"><a class="anchor" href="#references"></a>References</h2>

    <p>Concin N, Matias-Guiu X, Vergote I, et al ESGO/ESTRO/ESP
guidelines for the management of patients with endometrial
carcinoma. International Journal of Gynecologic Cancer Published Online
First: 18 December 2020. doi: 10.1136/ijgc-2020-002230</p>
    <h2 class="hasAnchor" id="author"><a class="anchor" href="#author"></a>Author</h2>

    <p>Derek Chiu</p>

    <h2 class="hasAnchor" id="examples"><a class="anchor" href="#examples"></a>Examples</h2>
    <pre class="examples"><span class='r-in'><span class='co'># without molecular classification</span></span>
<span class='r-in'><span class='va'>esmo2020_wo_eclass</span> <span class='op'>&lt;-</span> <span class='fu'><a href='https://rdrr.io/r/base/with.html'>with</a></span><span class='op'>(</span><span class='va'>emdb</span>, <span class='fu'>assign_esmo2020</span><span class='op'>(</span><span class='va'>stage_full</span>, <span class='va'>grade_rev</span>,</span>
<span class='r-in'><span class='va'>hist_rev_gr</span>, <span class='va'>myo</span>, <span class='va'>lvi</span><span class='op'>)</span><span class='op'>)</span></span>
<span class='r-in'><span class='fu'><a href='https://rdrr.io/r/base/table.html'>table</a></span><span class='op'>(</span><span class='va'>esmo2020_wo_eclass</span><span class='op'>)</span></span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> esmo2020_wo_eclass</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>               low      intermediate high-intermediate              high </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>                51               100               130               285 </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>          advanced        metastatic </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>                17                 6 </span>
<span class='r-in'></span>
<span class='r-in'><span class='co'># with molecular classification</span></span>
<span class='r-in'><span class='va'>eclass</span> <span class='op'>&lt;-</span> <span class='fu'><a href='https://rdrr.io/r/base/with.html'>with</a></span><span class='op'>(</span><span class='va'>emdb</span>, <span class='fu'><a href='assign_promise2015.html'>assign_promise2015</a></span><span class='op'>(</span><span class='va'>mmr_ihc_2</span>, <span class='va'>pole_mut</span>, <span class='va'>p53</span><span class='op'>)</span><span class='op'>)</span></span>
<span class='r-in'><span class='va'>esmo2020_w_eclass</span> <span class='op'>&lt;-</span> <span class='fu'><a href='https://rdrr.io/r/base/with.html'>with</a></span><span class='op'>(</span><span class='va'>emdb</span>, <span class='fu'>assign_esmo2020</span><span class='op'>(</span><span class='va'>stage_full</span>, <span class='va'>grade_rev</span>,</span>
<span class='r-in'><span class='va'>hist_rev_gr</span>, <span class='va'>myo</span>, <span class='va'>lvi</span>, <span class='va'>eclass</span><span class='op'>)</span><span class='op'>)</span></span>
<span class='r-in'><span class='fu'><a href='https://rdrr.io/r/base/table.html'>table</a></span><span class='op'>(</span><span class='va'>esmo2020_w_eclass</span><span class='op'>)</span></span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> esmo2020_w_eclass</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>               low      intermediate high-intermediate              high </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>                75                53                89               265 </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>          advanced        metastatic </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>                38                 6 </span>
<span class='r-in'></span>
<span class='r-in'><span class='co'># with molecular classification and residual disease</span></span>
<span class='r-in'><span class='va'>esmo2020_w_eclass_res</span> <span class='op'>&lt;-</span> <span class='fu'><a href='https://rdrr.io/r/base/with.html'>with</a></span><span class='op'>(</span><span class='va'>emdb</span>, <span class='fu'>assign_esmo2020</span><span class='op'>(</span><span class='va'>stage_full</span>, <span class='va'>grade_rev</span>,</span>
<span class='r-in'><span class='va'>hist_rev_gr</span>, <span class='va'>myo</span>, <span class='va'>lvi</span>, <span class='va'>eclass</span>, <span class='va'>residual</span><span class='op'>)</span><span class='op'>)</span></span>
<span class='r-in'><span class='fu'><a href='https://rdrr.io/r/base/table.html'>table</a></span><span class='op'>(</span><span class='va'>esmo2020_w_eclass_res</span><span class='op'>)</span></span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> esmo2020_w_eclass_res</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>               low      intermediate high-intermediate              high </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>                70                53                89               239 </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>          advanced        metastatic </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>                32                 6 </span>
</pre>
  </div>
  <div class="col-md-3 hidden-xs hidden-sm" id="pkgdown-sidebar">
    <nav id="toc" data-toggle="toc" class="sticky-top">
      <h2 data-toc-skip>Contents</h2>
    </nav>
  </div>
</div>


      <footer>
      <div class="copyright">
  <p>Developed by Derek Chiu, Samuel Leung.</p>
</div>

<div class="pkgdown">
  <p>Site built with <a href="https://pkgdown.r-lib.org/">pkgdown</a> 1.6.1.</p>
</div>

      </footer>
   </div>

  


  </body>
</html>


